Novavax Inc (NVAX)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$8.02

Buy

$8.03

arrow-down$-0.075 (-0.93%)

Prices updated at 13 Mar 2025, 15:36 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.
NASDAQ
arrow-down-1.5%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
$8.50 - $8.03
$23.86 - $3.81
-
1,302.84m
-
-
889,497
-
8,079,291.85
2.93
161.94m
US6700024010
-1.23
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.